February 25, 2018
Article
Evidence-Based Oncology
Dr Alvarnas is editor in chief and director of Value-Based Analytics at City of Hope, Duarte, California.
February 22, 2018
Article
Evidence-Based Oncology
CAR T- cell therapies are among the most expensive ever invented. For now, there’s a lot of uncertainty, as both government and commercial insurers, and a handful of the nation’s leading cancer centers, navigate a reimbursement structure that truly has no precedent.
February 21, 2018
Article
Ipililumumab's role in treating melanoma will change, as the immunotherapy will likely become part of different combinations than we see today.
February 21, 2018
Article
Evidence-Based Oncology
Last year's approval of trastuzumab biosimilar, Ogivri, will be the first competitor to blockbuster drug, Herceptin, for the treatment of HER2-positive breast cancer since its discovery.
February 21, 2018
Article
Evidence-Based Oncology
Two stories--of taking part in clinical trials, and of serving as a voice for patients among scientists who run them--highlight how the advances in cancer are built on the trust between those living with the disease and the clinicians on the frontiers of care.
February 20, 2018
Article
Evidence-Based Oncology
This review assesses the current molecular testing landscape for non–small-cell lung cancer in the United States.